RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
| Location: | District of Columbia |
|---|---|
| Posted: | Oct 29, 2024 |
| Due: | Nov 15, 2024 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Solicitation No: | RRPV-24-02-OralVx |
| Publication URL: | To access bid details, please log in. |
- Contract Opportunity Type: Special Notice (Updated)
- Updated Published Date: Oct 29, 2024 01:06 pm EDT
- Original Published Date: Sep 10, 2024 07:04 am EDT
- Updated Response Date: Nov 15, 2024 01:00 pm EST
- Original Response Date: Oct 18, 2024 01:00 pm EDT
- Inactive Policy: 15 days after response date
- Updated Inactive Date: Nov 30, 2024
- Original Inactive Date: Nov 02, 2024
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN42 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH
-
NAICS Code:
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
-
Place of Performance:
DCUSA
This solicitation summary is to notify all potential offerors of a Request for Project Proposals (RPP) issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA) titled, "NextGen Oral Formulation Vaccines for COVID-19". The purpose of this effort is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, improve our understanding of their potential, and to provide better COVID-19 solutions and bolster preparedness and response against future health security threats. The full RPP and information on joining the consortium can be accessed through the RRPV website at www.rrpv.org.
Amended to extend the due date from 18 October 2024 to 1 November 2024.
Amended to extend the due date from 1 November 2024 to 15 November 2024.
- O’NEILL HOUSE OFFICE BUILDING
- WASHINGTON , DC 20515
- USA
- Rebecca Harmon
- rebecca.harmon@ati.org
- Oct 29, 2024 01:06 pm EDTSpecial Notice (Updated)
- Oct 01, 2024 03:02 pm EDT Special Notice (Updated)
- Sep 10, 2024 07:04 am EDT Special Notice (Original)
Related Document
| Sep 10, 2024 | [Special Notice (Original)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
| Oct 1, 2024 | [Special Notice (Updated)] RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19 |
With GovernmentContracts, you can:
- Find more opportunities and win more business
- Receive daily alerts for all new bid opportunities
- Get contract opportunities matched to your business
See also
Follow Systematic Targeting Of MicroPlastics (STOMP) Active Contract Opportunity Notice ID ARPA-H-SOL-26-152 Related
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Bid Due: 6/22/2026
Follow Request for Information 2 - Next Generation of the GSA SmartPay(r) Master
GENERAL SERVICES ADMINISTRATION
Bid Due: 6/19/2026
Follow Veteran Decedent Memorial Data/Information Analysis & Visualization Active Contract Opportunity Notice ID
VETERANS AFFAIRS, DEPARTMENT OF
Bid Due: 4/07/2027
Follow Department of Education Small Business Innovation Research (SBIR) Direct to Phase II
EDUCATION, DEPARTMENT OF
Bid Due: 6/29/2026